Company news

XOMA Royalty Corporation news in 2020

XOMA Royalty Corporation's news releases, calls and decks from 2020, newest first.

View company

XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering

December 20, 2020

XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock

December 9, 2020

XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock

December 9, 2020

XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development

November 15, 2020

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

November 10, 2020

XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance

November 2, 2020

XOMA Earns $25 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 2 Clinical Study in Metastatic Pancreatic Cancer

October 27, 2020

XOMA Earns $1.9 Million Associated with Two Partner Developments

October 13, 2020

XOMA Reports Second Quarter 2020 Financial Results

August 5, 2020

XOMA Announces Natasha Hernday Joins its Board of Directors

June 30, 2020

XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update

May 4, 2020

XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights

March 9, 2020

Decks in 2020